Ketopat Eye Drop is a combination ophthalmic solution containing Ketorolac tromethamine 0.4% w/v and Olopatadine hydrochloride 0.1% w/v, formulated for the management of ocular inflammation and allergic conjunctivitis. Ketorolac, a non-steroidal anti-inflammatory drug (NSAID), exerts its effect by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins responsible for pain, inflammation, and swelling in ocular tissues. Olopatadine, a selective histamine H1 receptor antagonist with mast cell stabilizing properties, effectively alleviates symptoms associated with allergic conjunctivitis such as itching, redness, and swelling by preventing the release of histamine and other inflammatory mediators. Ketopat Eye Drop is indicated for the relief of ocular itching due to allergic conjunctivitis and for the reduction of inflammation following ocular surgery or injury. The combination provides both anti-inflammatory and anti-allergic actions, offering rapid symptomatic relief and improved patient comfort. It is typically administered as one or two drops in the affected eye(s) two to four times daily, as directed by a healthcare professional. Caution is advised in patients with hypersensitivity to any component or with a history of corneal epithelial defects. Proper usage and adherence to prescribed dosing are essential to minimize potential adverse effects such as transient burning or stinging upon instillation.